Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver and Intrahepatic Biliary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Testing effectiveness (Phase 2)Looking for participantsNCT06852820
What this trial is testing

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Liver CancerHepatocellular CarcinomaMetastatic Liver Cancer
Melissa Lumish 10
Not applicableEnded earlyNCT05718882
What this trial is testing

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Who this might be right for
Liver CancerHepatocellular CarcinomaResistant Cancer
RenJi Hospital 5
Testing effectiveness (Phase 2)Looking for participantsNCT05440708
What this trial is testing

TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated 193
Not applicableUnknownNCT05360420
What this trial is testing

Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure

Who this might be right for
Liver CancerLiver Cirrhosis
Tianjin Third Central Hospital 6,730
Not applicableUnknownNCT02321579
What this trial is testing

Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities

Who this might be right for
Liver CirrhosisLiver Cancer
Taichung Veterans General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Testing effectiveness (Phase 2)UnknownNCT05550025
What this trial is testing

TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT07034950
What this trial is testing

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

Who this might be right for
Hepatic NeoplasmHepatic Cancer
The First Affiliated Hospital of Xiamen University 79
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableUnknownNCT05806333
What this trial is testing

[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity

Who this might be right for
Liver Cancer
Jilin University 60
Early research (Phase 1)UnknownNCT06144385
What this trial is testing

A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Who this might be right for
Liver CarcinomaHepatic Cell Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd. 20
Not applicableWithdrawnNCT05292443
What this trial is testing

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

Who this might be right for
Primary Liver CancerHepatocellular CarcinomaIntrahepatic Cholangiocarcinoma+1 more
Geneplus-Beijing Co. Ltd.
Not applicableUnknownNCT00172640
What this trial is testing

Genetic Studies in Liver Cancer Patients

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 40
Not applicableActive Not RecruitingNCT07207343
What this trial is testing

Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging.

Who this might be right for
Liver CancerHIFU
National Taiwan University Hospital 38
Early research (Phase 1)Study completedNCT00230347
What this trial is testing

Evaluation of Stereotactic Radiosurgery For Liver Malignancies

Who this might be right for
CholangiocarcinomaLiver CancerAdenocarcinoma
Stanford University 20
Not applicableUnknownNCT05889949
What this trial is testing

Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

Who this might be right for
RadiomicsHepatocellular Carcinoma (HCC)Transcatheter Arterial Chemoembolization (TACE)+2 more
Sun Yat-sen University 200
Not applicableLooking for participantsNCT05184790
What this trial is testing

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Who this might be right for
Arrhythmias, CardiacBreast CancerProstatic Cancer+6 more
University of Sydney 300
Large-scale testing (Phase 3)Active Not RecruitingNCT03533582
What this trial is testing

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Who this might be right for
Childhood Hepatocellular CarcinomaChildhood Malignant Liver NeoplasmFibrolamellar Carcinoma+2 more
Children's Oncology Group 537
Not applicableActive Not RecruitingNCT07437859
What this trial is testing

Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

Who this might be right for
Primary Liver Cancer
Peking Union Medical College Hospital 60
Next Page